Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)

被引：44

作者：

Byington, RP

Miller, ME

Herrington, D

Riley, W

Pitt, B

Furberg, CD

Hunninghake, DB

Mancini, GBJ

机构：

[1] Department of Public Health Sciences, Bowman Gray School of Medicine, Medical Center Boulevard, Winston Salem, NC

[2] Department of Public Health Sciences, Bowman Gray School of Medicine, Medical Center Boulevard, Winston-Salem

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1997年 / 80卷 / 08期

关键词：

D O I：

10.1016/S0002-9149(97)00611-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial is the first angiographic clinical trial to be designed to test whether an agent can slow or even reverse the progression of early coronary atherosclerosis in patients with documented disease, In addition, a subset of patients are undergoing carotid ultrasound examinations, providing a unique opportunity to assess and correlate disease progression in 2 arterial beds.

引用

页码：1087 / &

页数：5

共 8 条

[1] PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II) [J].

CROUSE, JR ;

BYINGTON, RP ;

BOND, MG ;

ESPELAND, MA ;

CRAVEN, TE ;

SPRINKLE, JW ;

MCGOVERN, ME ;

FURBERG, CD .

AMERICAN JOURNAL OF CARDIOLOGY, 1995, 75 (07) :455-459

[2] EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS [J].

FURBERG, CD ;

ADAMS, HP ;

APPLEGATE, WB ;

BYINGTON, RP ;

ESPELAND, MA ;

HARTWELL, T ;

HUNNINGHAKE, DB ;

LEFKOWITZ, DS ;

PROBSTFIELD, J ;

RILEY, WA ;

YOUNG, B .

CIRCULATION, 1994, 90 (04) :1679-1687

[3] COMPENSATORY ENLARGEMENT OF HUMAN ATHEROSCLEROTIC CORONARY-ARTERIES [J].

GLAGOV, S ;

WEISENBERG, E ;

ZARINS, CK ;

STANKUNAVICIUS, R ;

KOLETTIS, GJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (22) :1371-1375

[4]

KRAMSCH DM, 1995, J HUM HYPERTENS, V9, pS3

[5] RETARDATION OF ANGIOGRAPHIC PROGRESSION OF CORONARY-ARTERY DISEASE BY NIFEDIPINE - RESULTS OF THE INTERNATIONAL NIFEDIPINE TRIAL ON ANTIATHEROSCLEROTIC THERAPY (INTACT) [J].

LICHTLEN, PR ;

HUGENHOLTZ, PG ;

RAFFLENBEUL, W ;

HECKER, H ;

JOST, S ;

DECKERS, JW .

LANCET, 1990, 335 (8698) :1109-1113

[6]

*PRINC INV CASS TH, 1981, CIRCULATION S1, V63, P1

[7]

TULENKO TN, 1995, J CARDIOVASC PHAR SA, V26, pS11

[8]

WATERS D, 1990, CIRCULATION, V821, P940

← 1 →